Abiopharma

🔍 Van Deun Jona M (Executive)

Company: NELNET INC (NNI)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 407 shares of Class A Common Stock at $110.76 per share (Direct)
  Date: 2026-06-15 | Code: A | equity_swap_involved: false | shares_owned_after: 1,111.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,219 shares of Phantom Stock (Derivative)
  Date: 2026-06-15 | Code: A | equity_swap_involved: false | shares_owned_after: 8,398.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3, F4

Footnotes:

• F1: These shares were granted pursuant to the issuer's Directors Stock Compensation Plan.
• F2: 1-for-1.
• F3: The shares of phantom stock were granted pursuant to the issuer's Directors Stock Compensation Plan. They will become payable in shares of Class A Common Stock promptly after the time of termination of the reporting person's service as a member of the issuer's Board of Directors. The shares will be payable in a lump sum promptly after the time of termination of the reporting person's service as a member of the issuer's Board, or in up to five annual installments, commencing promptly after the time of termination of the reporting person's service on the issuer's Board, as elected by the reporting person.
• F4: Includes 74 share acquired since June 18, 2025 pursuant to the dividend reinvestment feature of the issuer's Directors Stock Compensation Plan.